Additionally, we determined the optimal cut-off value of AIP and used AIP as a new discriminator to establish a three-variable discriminant model (model 3) for NAFLD in both the training set and the validation set. Here, AIP is linked to metabolic dysfunction-associated steatotic liver disease.